Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
48.65
-1.05 (-2.11%)
Feb 20, 2026, 10:24 AM EST - Market open
Moderna Employees
Moderna had 5,800 employees as of December 31, 2024. The number of employees increased by 200 or 3.57% compared to the previous year.
Employees
5,800
Change (1Y)
200
Growth (1Y)
3.57%
Revenue / Employee
$335,172
Profits / Employee
-$486,552
Market Cap
19.01B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 5,800 | 200 | 3.57% |
| Dec 31, 2023 | 5,600 | 1,700 | 43.59% |
| Dec 31, 2022 | 3,900 | 1,200 | 44.44% |
| Dec 31, 2021 | 2,700 | 1,400 | 107.69% |
| Dec 31, 2020 | 1,300 | 470 | 56.63% |
| Dec 31, 2019 | 830 | 70 | 9.21% |
| Dec 31, 2018 | 760 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,040 |
| Incyte | 2,844 |
| Genmab | 2,681 |
| Ascendis Pharma | 1,189 |
| Exelixis | 1,077 |
| Ionis Pharmaceuticals | 1,069 |
| Revolution Medicines | 809 |
| Roivant Sciences | 750 |
MRNA News
- 21 hours ago - BioNTech sues Moderna for patent infringement over COVID-19 shots - Reuters
- 1 day ago - Moderna to Present at Upcoming Conferences in March 2026 - Accesswire
- 1 day ago - FDA Makes U-Turn Again On Moderna New Flu Vaccine Review, Stock Soars - Benzinga
- 1 day ago - FDA agrees to review Moderna's mRNA flu vaccine application in a reversal - CNBC
- 1 day ago - Moderna Shares Rally 6% After FDA Reverses Decision Not To Review Flu Vaccine - Forbes
- 2 days ago - Moderna got the FDA to change its mind and review its flu vaccine after some concessions - Market Watch
- 2 days ago - FDA reverses decision not to review Moderna's new flu vaccine - New York Post
- 2 days ago - Moderna Says FDA Will Review Its Flu Vaccine. The Stock Is Rising. - Barrons